Inventor
BUMCROT DAVID A
US25 patents
⚠️ This page may combine multiple inventors who share the name “BUMCROT DAVID A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EDITAS MEDICINE INC
14 patentsUS10253312B2Apr 9, 2019
CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10)
EDITAS MEDICINE INC13 citations90
US9938521B2Apr 10, 2018
CRISPR/CAS-related methods and compositions for treating leber's congenital amaurosis 10 (LCA10)
EDITAS MEDICINE INC12 citations90
US11028388B2Jun 8, 2021
CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa
EDITAS MEDICINE INC7 citations82
US12234449B2Feb 25, 2025
CRISPR/Cas-related methods and compositions for treating Leber's congenital amaurosis 10 (LCA10)
EDITAS MEDICINE INC1 citations72
US11268086B2Mar 8, 2022
CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10)
EDITAS MEDICINE INC3 citations71
US11242525B2Feb 8, 2022
CRISPR/CAS-related methods and compositions for treating sickle cell disease
EDITAS MEDICINE INC2 citations70
US11339437B2May 24, 2022
Compositions and methods for treating CEP290-associated disease
EDITAS MEDICINE INC3 citations69
US11141493B2Oct 12, 2021
Compositions and methods for treating CEP290-associated disease
EDITAS MEDICINE INC2 citations69
US11001844B2May 11, 2021
CRISPR/Cas-related methods and compositions for treating herpes simplex virus
EDITAS MEDICINE INC2 citations69
US12545912B2Feb 10, 2026
CRISPR/Cas-related methods and compositions for treating usher syndrome and retinitis pigmentosa
EDITAS MEDICINE INC0 citations60
US12460231B2Nov 4, 2025
Crispr/CAS-related methods and compositions for treating primary open angle glaucoma
EDITAS MEDICINE INC0 citations60
US11834649B2Dec 5, 2023
CRISPR/CAS-related methods and compositions for treating herpes simplex virus
EDITAS MEDICINE INC0 citations59
US11390861B2Jul 19, 2022
CRISPR/cas-related methods and compositions for treating herpes simplex virus
EDITAS MEDICINE INC0 citations59
US11028394B2Jun 8, 2021
CRISPR/CAS-related methods and compositions for treating cystic fibrosis
EDITAS MEDICINE INC0 citations46
CAMP4 THERAPEUTICS CORP
4 patentsUS11542290B2Jan 3, 2023
Phenothiazine derivatives and uses thereof
CAMP4 THERAPEUTICS CORP2 citations70
US12145963B2Nov 19, 2024
Phenothiazine derivatives and uses thereof
CAMP4 THERAPEUTICS CORP0 citations59
US11266655B2Mar 8, 2022
Methods and compositions for treating urea cycle disorders
CAMP4 THERAPEUTICS CORP1 citations51
US12319916B2Jun 3, 2025
Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAs
CAMP4 THERAPEUTICS CORP0 citations50
HARVARD COLLEGE
3 patentsUS6664075B2Dec 16, 2003
Nucleic acids encoding hedgehog proteins
HARVARD COLLEGE42 citations95
US6576237B1Jun 10, 2003
Vertebrate tissue pattern-inducing proteins, and uses related thereto
HARVARD COLLEGE55 citations95
US6165747ADec 26, 2000
Nucleic acids encoding hedgehog proteins
HARVARD COLLEGE69 citations95